putting what you do into words

Publications

Marisa C. (Ziegler) Greenfield Publications

Edwards DS, Liu S, Barrett JA, Harris AR, Looby RJ, Ziegler MC, Heminway SJ, Carroll TR. New and versatile ternary ligand system for technetium radiopharmaceuticals: water-soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc. Bioconjugate Chemistry. 1997;8(2):146-54.

Edwards DS, Liu S, Barrett JA, Harris AR, Looby RJ, Ziegler MC, Heminway SJ, Carroll TR. New and Versatile Ternary Ligand System for Technetium Radiopharmaceuticals: Water Soluble Phosphines and Tricine as Coligands in Labeling a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antagonist with 99mTc. Bioconjugate Chemistry. 1998;9(5):634.

Edwards DS, Liu S, Ziegler MC, Harris AR, Crocker AC, Heminway SJ, and Barrett JA. RP463: A Stabilized Technetium-99m Complex of a Hydrazino Nicotinamide Derivatized Chemotactic Peptide for Infection Imaging. Bioconjugate Chemistry. 1999,10(5):884–891.

Liu S, Ziegler MC, Edwards DS. Radio-LC-MS for the Characterization of 99mTc-Labeled Bioconjugates. Bioconjugate Chemistry. 2000;11(1):113–117.

Liu S, Edwards DS, Ziegler MC, Harris AR, Hemingway SJ, and Barrett JA. 99mTc-Labeling of a Hydrazinonicotinamide-Conjugated Vitronectin Receptor Antagonist Useful for Imaging Tumors. Bioconjugate Chemistry. 2001;12(4):624–629.

Liu S, Edwards DS, Harris AR, Ziegler MC, Poirier MJ, Ewels BA, Diluzio WR, Hui P, Towards developing a non-SnCl2 formulation for RP444, a new radiopharmaceutical for thrombus imaging. Journal of Pharmaceutical Sciences. 2001;90(2):114-123.

Liu S, Cheung E, Ziegler MC, Rajopadhye M, Edwards DS. (90)Y and (177)Lu labeling of a DOTA-conjugated vitronectin receptor antagonist useful for tumor therapy. Bioconjugate Chemistry. 2001;12(4):559-68.

Comments are closed.

© 2018 Greenfield Medical Writing   |   351.201.9045